By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Advancing drug development using Artificial Intelligence and Machine Learning (AI/ML) to analyze116.67K100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States116.67K100.00%